Smith Hunter C
SEC insider (Form 3/4/5 filer). CIK 0001636385. Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM). 57 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.
Companies Smith Hunter C has filed insider reports for
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Officer, Chief Financial Officer
Smith Hunter C
CIK: 0001636385
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RHYTHM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (57 total)
- Aug 31, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect11.5K shares at avg. $105.37$1.2M - Aug 31, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect57.2K shares at avg. $25.79$1.5M - Aug 31, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect28.2K shares at avg. $106.20$3.0M - Aug 31, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect23.1K shares at avg. $104.59$2.4M - May 18, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect3K shares at avg. $17.87$54K - Mar 2, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect6.1K shares at avg. $6.80$41K - Feb 19, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect800 shares at avg. $102.10$82K - Feb 19, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect1.3K shares at avg. $100.27$131K - Feb 19, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect1.7K shares at avg. $100.92$171K - Feb 19, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect585 shares at avg. $103.28$60K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 11,514 | $105.37 | $1,213,232 | Direct |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 57,187 | $25.79 | $1,474,853 | Direct |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 28,188 | $106.20 | $2,993,647 | Direct |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 23,072 | $104.59 | $2,413,034 | Direct |
| May 18, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 3,000 | $17.87 | $53,610 | Direct |
| Mar 2, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 6,099 | $6.80 | $41,473 | Direct |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 800 | $102.10 | $81,676 | Direct |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 1,308 | $100.27 | $131,153 | Direct |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 1,692 | $100.92 | $170,755 | Direct |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 585 | $103.28 | $60,420 | Direct |
1-10 of 57 transactions